Less frequent Ocrevus infusions are just as effective in controlling MS, but may help limit the risk of side effects, per a ...

The recent volatility in our stock appears to be driven by misconceptions and a lack of understanding about our business and long-term strategy, but I want to reassure our investors that there have ...

Melvin Mann, diagnosed with chronic myeloid leukemia in 1994, participated in a clinical trial for Imatinib that extended his ...

This study represents the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein, offering the potential for direct blood glucose measurement without the limitations ...

BROOMFIELD, Colo. - Aclarion, Inc. (NASDAQ: ACON, ACONW), a healthcare technology company, announced today that it has raised nearly $20 million in gross proceeds since January 1, 2025. This funding ...

A small trial enrolled 62 people with RRMS who showed signs of cognitive dysfunction to test the effectiveness of acupuncture ...

Cancer is affecting increasing numbers of young women with the hormone oestrogen thought to play to a central role ...

Hemlibra was found to ease pain and improve quality of life for hemophilia A patients, even those with long-term joint damage ...

"While physical exercise is known to reduce cognitive decline, the cellular mechanisms behind its neuroprotective effects ...

Alzheimer's impacts almost one million people in the UK. Now, scientists claim that a particular exercise may help in ...

Merck is ending a Phase 3 trial of Winrevair early so all PAH patients in HYPERION can start active treatment with the drug ...

Baron Funds, an investment management company, released its “Baron Small Cap Fund” fourth-quarter 2024 investor letter. A ...